Platelet rich plasma in male female an androgenetic alopecia

A randomised prospective case control study on platelet rich plasma in male androgenetic alopecia and female pattern hair loss, and to compare pre and post treatment trichoscopic feature in male androgenetic alopecia female pattern hairloss

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/03/063524

Enrollment

100

Registered

2024-03-04

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L648- Other androgenic alopecia

Interventions

Intervention1: Platelet rich plasma: Intrademal injection on scalp in male and female androgenetic alopecia at 4 week, 8 week and 12 week Control Intervention1: Normal Saline: Intrademal injection in

Eligibility

Inclusion criteria

Inclusion criteria: Treatment naive Grade 2-5 Male Androgenetic alopecia (Norwood hamilton scale) Grade 2-5 Female Androgenetic alopecia (Sinclair Scale)

Exclusion criteria

Exclusion criteria: All pregnant females Those on any other hormonal therapy Grade 6 and 7 of hamilton norwood AGA patients

Design outcomes

Primary

Measure	Time frame
Efficacy of platelet rich plasma in male and female andriogenetic alopecia in 100 patientsTimepoint: Baseline, 4 weeks, 8weeks, 12 weeks, 16 weeks, 20 weeks, 24 weeks	—

Secondary

Measure	Time frame
Adverse effectTimepoint: 6 months	—

Countries

India

Contacts

Public ContactAbhijeet Kumar Jha

Patna medical College

drabhijeetjha@gmail.com9631444797

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026